Full Text
Pharmacoeconomic Evaluation of Sorafenib As First-Line Treatment for Advanced Hepatocellular Carcinoma

Abstract

Authors

Z Naumovska A Kapedanovska Nestorovska A Grozdanova L Suturkova A Dimovski Z Sterjev

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×